Georgia Bourlotos
YOU?
Author Swipe
View article: <scp>BCG</scp> Intolerance in Nonmuscle Invasive Bladder Cancer—A Systematic Review
<span>BCG</span> Intolerance in Nonmuscle Invasive Bladder Cancer—A Systematic Review Open
Background Most patients with localized bladder cancer are initially managed with endoscopic resection. For high‐grade nonmuscle invasive bladder cancer (NMIBC), intravesical Bacillus Calmette‐Guerin (BCG) therapy is the gold standard adju…
View article: BCG induced lower urinary tract symptoms during treatment for NMIBC—Mechanisms and management strategies
BCG induced lower urinary tract symptoms during treatment for NMIBC—Mechanisms and management strategies Open
Non-muscle invasive bladder cancer (NMIBC) accounts for ~70–75% of total bladder cancer tumors and requires effective early intervention to avert progression. The cornerstone of high-risk NMIBC treatment involves trans-urethral resection o…